Comments on:

Manhattan Moment: Pushing antibiotics off of their own 'fiscal cliff'

Back to the article » |
With all eyes on the "fiscal cliff" posturing in Washington, the rising cost of pharmaceutical research and development is perhaps not as exciting a topic -- yet, in the long run, it may be just as important to the nation's future health. In what seems like a constant refrain from the pharmaceutical industry, the Office of Health Economics, a U.K. think tank, found that total R&D costs for...

To learn more about commenting on and our community guidelines, please see our comments FAQ.